DERM
Journey Medical Stock Analysis
AI Rating
- Quality0/10
- Growth↓ 0/10
- Momentum↑ 7/10
DERM Growth
- Revenue Y/Y↓ 2.82%
- EPS Y/Y↑ 62.77%
- FCF Y/Y↑ 85.89%
DERM Profitability
- Gross margin ↑ 70.20%
- EPS margin↓ -14.60%
- ROIC↓ -28.40%
DERM Risk
- Debt / Equity↓ 1.0
- Debt / FCF↓ 0.1
- Interest coverage↓ -1.4
Journey Medical stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.